6533b859fe1ef96bd12b7546

RESEARCH PRODUCT

Activation of tumor initiating cells during anti-angiogenic therapies promotes tumor progression and relapse formation in hepatocellular carcinoma

D BeckerCarolin CzaudernaPeter P. GrimmingerHauke LangD CastvenMa WörnsJens U. MarquardtPeter R. GalleSnorri S. Thorgeirsson

subject

Tumor progressionbusiness.industryHepatocellular carcinomaAnti angiogenicImmunologyGastroenterologyCancer researchmedicinemedicine.diseasebusinessTumor Initiating Cellshttps://doi.org/10.1055/s-0036-1597456